AbbVie Inc.

Total Valuation

AbbVie Inc. carries a market capitalization of 397.12B, placing it among publicly traded companies globally. Its enterprise value stands at 447.84B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

AbbVie Inc. currently has 1.77B shares outstanding.

Valuation Ratios

AbbVie Inc. trades at a trailing price-to-earnings ratio of 105.73. The price-to-sales ratio is 6.12, and the price-to-book ratio stands at -21.53.

Enterprise Valuation

On an enterprise value basis, AbbVie Inc. trades at an EV/EBITDA multiple of 15.51 and an EV/FCF ratio of 18.47. The EV/Sales ratio of 7.13 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 21.49 provides insight into valuation relative to core operating earnings.

Financial Position

AbbVie Inc. maintains a current ratio of 0.80, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -1,101.91, indicating conservative leverage, while an interest coverage ratio of 9.92 demonstrates adequate ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, AbbVie Inc. has paid 2.33B in income taxes, reflecting an effective tax rate of 39.06.

Stock Price Statistics

AbbVie Inc.'s stock has gained approximately 17.37337% over the past 52 weeks. The 50-day moving average sits at 210.40, while the 200-day moving average is 220.17.

Income Statement

Over the trailing twelve months, AbbVie Inc. generated 62.82B in revenue and converted that into 3.64B in net income, yielding earnings per share of 2.05. EBITDA reached 28.88B, while operating income came in at 20.84B.

Balance Sheet

AbbVie Inc. holds 9.39B in cash and equivalents against 72.86B in total debt, resulting in a net debt position of 63.47B. Total book value stands at -17.85B, with working capital of -8.57B providing operational flexibility.

Cash Flow

AbbVie Inc. produced 21.22B in operating cash flow over the past twelve months. After subtracting -1.24B in capital expenditures, free cash flow totaled 19.98B - equivalent to 11.31 per share.

Margins

AbbVie Inc. operates with a gross margin of 70.68, reflecting its pricing power and cost economics. The operating margin of 33.18 and net profit margin of 5.79 provide insight into operational efficiency.

Dividends & Yields

The company's payout ratio of 324.05 indicates the proportion of earnings distributed to shareholders.

Scores

AbbVie Inc. posts an Altman Z-Score of 3.54, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.